Danaher price target lowered to $275 from $310 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Danaher to $275 from $310 and keeps a Buy rating on the shares. The stock reaction to Danaher’s Q1 results reflected confusion about underlying business mix and also raised the broader question of whether there is a structural shift in the underlying bioprocessing market according to investor feedback, the analyst tells investors in a research note. The firm believes Danaher now has "breathing room" to meet its financial targets in 2023.